Related references
Note: Only part of the references are listed.Improvement of thiol groups and total antioxidant capacity in patients with non-alcoholic fatty liver after treatment with pioglitazone
Tahmine Tavakoli et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2022)
NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis
Stephen A. Harrison et al.
HEPATOLOGY (2020)
Elafibranor: a potential drug for the treatment of nonalcoholic steatohepatitis (NASH)
Menso J. Westerouen Van Meeteren et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Vitamin E is an effective treatment for nonalcoholic steatohepatitis in HIV mono-infected patients
Giada Sebastiani et al.
AIDS (2020)
Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA Phase 3 study design
Quentin M. Anstee et al.
CONTEMPORARY CLINICAL TRIALS (2020)
A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial
Marcos Pedrosa et al.
CONTEMPORARY CLINICAL TRIALS (2020)
Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension
Naga Chalasani et al.
GASTROENTEROLOGY (2020)
Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension
Guadalupe Garcia-Tsao et al.
JOURNAL OF HEPATOLOGY (2020)
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Stephen A. Harrison et al.
JOURNAL OF HEPATOLOGY (2020)
Circulating microbiome in blood of different circulatory compartments
Robert Schierwagen et al.
GUT (2019)
Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications
Ralf Weiskirchen et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances
Keisaku Sato et al.
HEPATOLOGY (2019)
Saroglitazar Deactivates the Hepatic LPS/TLR4 Signaling Pathway and Ameliorates Adipocyte Dysfunction in Rats with High-Fat Emulsion/LPS Model-Induced Non-alcoholic Steatohepatitis
Noha F. Hassan et al.
INFLAMMATION (2019)
Advantages of adipose tissue stem cells over CD34+ mobilization to decrease hepatic fibrosis in Wistar rats
Marcela M. De Luna-Saldivar et al.
ANNALS OF HEPATOLOGY (2019)
Mesenchymal stem cells overexpressing hepatocyte nuclear factor-4 alpha alleviate liver injury by modulating anti-inflammatory functions in mice
Zhenxiong Ye et al.
STEM CELL RESEARCH & THERAPY (2019)
Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
Fernando Bril et al.
DIABETES CARE (2019)
The mesenchymal stem cell secretome as an acellular regenerative therapy for liver disease
Julia Driscoll et al.
JOURNAL OF GASTROENTEROLOGY (2019)
The dual PPAR-α/γ agonist saroglitazar ameliorates thioacetamide-induced liver fibrosis in rats through regulating leptin
Mirhan N. Makled et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2019)
Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASH
Jonathan D. Roth et al.
SCIENTIFIC REPORTS (2019)
REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis
Vlad Ratziu et al.
CONTEMPORARY CLINICAL TRIALS (2019)
Phase 3 drug pipelines in the treatment of non-alcoholic steatohepatitis
Yoshio Sumida et al.
HEPATOLOGY RESEARCH (2019)
Atorvastatin and Vitamin E Accelerates NASH Resolution by Dietary Intervention in a Preclinical Guinea Pig Model
Julie Hviid Klaebel et al.
NUTRIENTS (2019)
A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis
Stephen A. Harrison et al.
JOURNAL OF HEPATOLOGY (2019)
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Zobair M. Younossi et al.
LANCET (2019)
The therapeutic potential of induced hepatocyte-like cells generated by direct reprogramming on hepatic fibrosis
Suhyun Park et al.
STEM CELL RESEARCH & THERAPY (2019)
Emricasan Ameliorates Portal Hypertension and Liver Fibrosis in Cirrhotic Rats Through a Hepatocyte-Mediated Paracrine Mechanism
Jordi Gracia-Sancho et al.
HEPATOLOGY COMMUNICATIONS (2019)
New Perspectives in Liver Transplantation: From Regeneration to Bioengineering
Debora Bizzaro et al.
BIOENGINEERING-BASEL (2019)
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
Rohit Loomba et al.
HEPATOLOGY (2018)
Dual PPAR/agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models
Mukul R. Jain et al.
LIVER INTERNATIONAL (2018)
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
Juan Pablo Arab et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13 (2018)
CXCL10-induced IL-9 promotes liver fibrosis via Raf/MEK/ERK signaling pathway
Xiaoyun Guo et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Therapeutic potential of Bama miniature pig adipose stem cells induced hepatocytes in a mouse model with acute liver failure
Shuang Zhang et al.
CYTOTECHNOLOGY (2018)
Farnesoid X receptor modulators 2014-present: a patent review
Valentina Sepe et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2018)
A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
Scott L. Friedman et al.
HEPATOLOGY (2018)
Effects of FGF21-secreting adipose-derived stem cells in thioacetamide-induced hepatic fibrosis
Hwansu Kang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Pharmacotherapy for NASH: Current and emerging
Monica A. Konerman et al.
JOURNAL OF HEPATOLOGY (2018)
Hepatocyte transplantation and advancements in alternative cell sources for liver-based regenerative medicine
Charlotte A. Lee et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2018)
Emricasan, a pan-caspase inhibitor, improves survival and portal hypertension in a murine model of common bile-duct ligation
Akiko Eguchi et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2018)
NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Stephen A. Harrison et al.
LANCET (2018)
Bone morphogenetic protein 9 as a key regulator of liver progenitor cells in DDC-induced cholestatic liver injury
Annalisa Addante et al.
LIVER INTERNATIONAL (2018)
Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertib
Zobair M. Younossi et al.
LIVER INTERNATIONAL (2018)
Transplantation of bone marrow-derived endothelial progenitor cells and hepatocyte stem cells from liver fibrosis rats ameliorates liver fibrosis
Ling Lan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial
Stephen A. Harrison et al.
PLOS ONE (2018)
Therapeutic effect of hepatocyte growth factor-overexpressing bone marrow-derived mesenchymal stem cells on CCl4-induced hepatocirrhosis.
Yichi Zhang et al.
CELL DEATH & DISEASE (2018)
Isolation, cultivation, and characterization of human mesenchymal stem cells
Dolly Mushahary et al.
CYTOMETRY PART A (2018)
In vitro differentiated hepatic oval-like cells enhance hepatic regeneration in CCl4-induced hepatic injury
Sana Javaid Awan et al.
CELL BIOLOGY INTERNATIONAL (2017)
PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
Barbara Gross et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Hepatogenic differentiation from human adipose-derived stem cells and application for mouse acute liver injury
De-Liang Guo et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2017)
Statins Decrease the Risk of Decompensation in Hepatitis B Virus- and Hepatitis C Virus-Related Cirrhosis: A Population-Based Study
Fu-Ming Chang et al.
HEPATOLOGY (2017)
Fecal Microbiota Transplant From a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial
Jasmohan S. Bajaj et al.
HEPATOLOGY (2017)
Intestinal fungi contribute to development of alcoholic liver disease
An-Ming Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Targeting the gut-liver axis in liver disease
Reiner Wiest et al.
JOURNAL OF HEPATOLOGY (2017)
Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice
Gladys Ferrere et al.
JOURNAL OF HEPATOLOGY (2017)
Oncostatin M in William's E medium is suitable for initiation of hepatocyte differentiation in human induced pluripotent stem cells
Minoru Tomizawa et al.
MOLECULAR MEDICINE REPORTS (2017)
Phase 1-2 pilot clinical trial in patients with decompensated liver cirrhosis treated with bone marrow-derived endothelial progenitor cells
Delia D'Avola et al.
TRANSLATIONAL RESEARCH (2017)
Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction
Wei-Wei Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Ultrastructural Characteristics of Rat Hepatic Oval Cells and Their Intercellular Contacts in the Model of Biliary Fibrosis: New Insights into Experimental Liver Fibrogenesis
Joanna Maria Lotowska et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2017)
Comparison of bone marrow-vs. adipose tissue-derived mesenchymal stem cells for attenuating liver fibrosis
Tianpao Hao et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Improvement of non-alcoholic steatohepatitis by hepatocyte-like cells generated from iPSCs with Oct4/Sox2/Klf4/Parp1
Yueh Chien et al.
Oncotarget (2017)
Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model
Yuko Tokunaga et al.
SCIENTIFIC REPORTS (2017)
Oval Cells Contribute to Fibrogenesis of Marginal Liver Grafts under Stepwise Regulation of Aldose Reductase and Notch Signaling
Xiao-Bing Liu et al.
THERANOSTICS (2017)
Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial
Kiminori Kimura et al.
EBIOMEDICINE (2017)
Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis
Sehrish Kamal et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Hepatic stellate cells as key target in liver fibrosis
Takaaki Higashi et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Healthy Donor Fecal Microbiota Transplantation in Steroid-Ineligible Severe Alcoholic Hepatitis: A Pilot Study
Cyriac Abby Philips et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis
S. A. Harrison et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus A Randomized Trial
Kenneth Cusi et al.
ANNALS OF INTERNAL MEDICINE (2016)
Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells
Jianjun Wang et al.
CELL BIOCHEMISTRY AND FUNCTION (2016)
Emerging therapeutic targets for the treatment of hepatic fibrosis
Paolo Fagone et al.
DRUG DISCOVERY TODAY (2016)
Bone marrow-derived mesenchymal stem cells effectively regenerate fibrotic liver in bile duct ligation rat model
Hoda E. Mohamed et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2016)
Mesenchymal stromal cells and liver fibrosis: a complicated relationship
Debashis Haldar et al.
FASEB JOURNAL (2016)
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Vlad Ratziu et al.
GASTROENTEROLOGY (2016)
Statins and portal hypertension: A tale of two models
Juan P. Arab et al.
HEPATOLOGY (2016)
Statins for Prevention of Cardiovascular Disease in Adults Evidence Report and Systematic Review for the US Preventive Services Task Force
Roger Chou et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Nuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver Disease
Claudia D. Fuchs et al.
SEMINARS IN LIVER DISEASE (2016)
Concise Review: Endothelial Progenitor Cells in Regenerative Medicine: Applications and Challenges
Mark Seow Khoon Chong et al.
STEM CELLS TRANSLATIONAL MEDICINE (2016)
3D Spheroid Culture Enhances the Expression of Antifibrotic Factors in Human Adipose-Derived MSCs and Improves Their Therapeutic Effects on Hepatic Fibrosis
Xuan Zhang et al.
STEM CELLS INTERNATIONAL (2016)
Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis
Eric Lefebvre et al.
PLOS ONE (2016)
Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis
Ryan E. Feaver et al.
JCI INSIGHT (2016)
Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells
Lee-Won Chong et al.
BMC GASTROENTEROLOGY (2015)
Long-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver
Meritxell Huch et al.
CELL (2015)
Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: A randomized controlled trial
Priscila Pollo-Flores et al.
DIGESTIVE AND LIVER DISEASE (2015)
Bone marrow mononuclear cell transplantation improves mitochondrial bioenergetics in the liver of cholestatic rats
Daniela Caldas de Andrade et al.
EXPERIMENTAL CELL RESEARCH (2015)
Basic fibroblast growth factor-treated adipose tissue-derived mesenchymal stem cell infusion to ameliorate liver cirrhosis via paracrine hepatocyte growth factor
Wei-Ping Tang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
The boom in mini stomachs, brains, breasts, kidneys and more
Cassandra Willyard
NATURE (2015)
Vitamin E therapy for NAFLD/NASH
Masashi Yoneda et al.
NUTRITION (2015)
Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials
Ken Sato et al.
NUTRITION (2015)
Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/β-Catenin Reduces Liver Fibrosis in Mice
Yosuke Osawa et al.
EBIOMEDICINE (2015)
The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis
Fernando J. Barreyro et al.
LIVER INTERNATIONAL (2015)
Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance
Tom Luedde et al.
GASTROENTEROLOGY (2014)
Roles for Chemokines in Liver Disease
Fabio Marra et al.
GASTROENTEROLOGY (2014)
Generation of Functional Cholangiocyte-Like Cells From Human Pluripotent Stem Cells and HepaRG Cells
Noushin Dianat et al.
HEPATOLOGY (2014)
Obeticholic Acid, a Farnesoid X Receptor Agonist, Improves Portal Hypertension by Two Distinct Pathways in Cirrhotic Rats
Len Verbeke et al.
HEPATOLOGY (2014)
Alterations of the human gut microbiome in liver cirrhosis
Nan Qin et al.
NATURE (2014)
Bone marrow cell transplantation is associated with fibrogenic cells apoptosis during hepatic regeneration in cholestatic rats
Simone Nunes de Carvalho et al.
BIOCHEMISTRY AND CELL BIOLOGY (2013)
Bone Marrow Mononuclear Cell Transplantation Increases Metalloproteinase-9 and 13 and Decreases Tissue Inhibitors of Metalloproteinase-1 and 2 Expression in the Liver of Cholestatic Rats
Simone Nunes de Carvalho et al.
CELLS TISSUES ORGANS (2013)
Special issue on Oxidative stress and redox signaling in the gastrointestinal tract and related organs for Free Radical Research Involvement of free radicals and oxidative stress in NAFLD/NASH
Y. Sumida et al.
FREE RADICAL RESEARCH (2013)
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Sunder Mudaliar et al.
GASTROENTEROLOGY (2013)
Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model
Masaharu Sakamoto et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Decoding cell death signals in liver inflammation
Catherine Brenner et al.
JOURNAL OF HEPATOLOGY (2013)
In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration
Meritxell Huch et al.
NATURE (2013)
Vascularized and functional human liver from an iPSC-derived organ bud transplant
Takanori Takebe et al.
NATURE (2013)
A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity
Radina Kostadinova et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis
Yan-Yan Ma et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Adipose-Derived Stem Cells Can Abrogate Chemical-Induced Liver Fibrosis and Facilitate Recovery of Liver Function
Horng-Jyh Harn et al.
CELL TRANSPLANTATION (2012)
Prevention of liver fibrosis and liver reconstitution of DMN-treated rat liver by transplanted EPCs
Toru Nakamura et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2012)
Nicotinamide Adenine Dinucleotide Phosphate Oxidase in Experimental Liver Fibrosis: GKT137831 as a Novel Potential Therapeutic Agent
Tomonori Aoyama et al.
HEPATOLOGY (2012)
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)
Rene Adam et al.
JOURNAL OF HEPATOLOGY (2012)
Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease
Geoffrey Porez et al.
JOURNAL OF LIPID RESEARCH (2012)
Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/II clinical trial in NASH
Meir Mizrahi et al.
JOURNAL OF INFLAMMATION RESEARCH (2012)
Bone marrow cells obtained from cirrhotic rats do not improve function or reduce fibrosis in a chronic liver disease model
Elida Gripp Mannheimer et al.
CLINICAL TRANSPLANTATION (2011)
Decreased collagen types I and IV, laminin, CK-19 and α-SMA expression after bone marrow cell transplantation in rats with liver fibrosis
S. N. Carvalho et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2010)
FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats
Sabrina Cipriani et al.
JOURNAL OF LIPID RESEARCH (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials
Markus Schuerks et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Farnesoid X Receptor Critically Determines the Fibrotic Response in Mice but Is Expressed to a Low Extent in Human Hepatic Stellate Cells and Periductal Myofibroblasts
Peter Fickert et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver
Montserrat Moreno et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial
Juan G. Abraldes et al.
GASTROENTEROLOGY (2009)
The regulation of inflammation by galectin-3
Neil C. Henderson et al.
IMMUNOLOGICAL REVIEWS (2009)
Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers The Selenium and Vitamin E Cancer Prevention Trial ( SELECT)
Scott M. Lippman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Transplanted Endothelial Progenitor Cells Ameliorate Carbon Tetrachloride-Induced Liver Cirrhosis in Rats
Feng Liu et al.
LIVER TRANSPLANTATION (2009)
Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
Guruprasad P. Aithal et al.
GASTROENTEROLOGY (2008)
Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone
Yasushi Sato et al.
NATURE BIOTECHNOLOGY (2008)
Bone marrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury
Adriana B. Carvalho et al.
STEM CELLS (2008)
Endothetial progenitor cells contribute to accelerated liver regeneration
Pau Beaudry et al.
JOURNAL OF PEDIATRIC SURGERY (2007)
Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model
Toru Nakamura et al.
GASTROENTEROLOGY (2007)
Identification of hepatocytic and bile ductular cell lineages and candidate stem cells in bipolar ductular reactions in cirrhotic human liver
Hongchao Zhou et al.
HEPATOLOGY (2007)
Intrasplenic hepatocyte transplantation prolonged the survival in nagase analbuminemic rats with liver failure induced by common bile duct ligation
Masahiro Ito et al.
CELL TRANSPLANTATION (2007)
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Renata Belfort et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Kazutoshi Takahashi et al.
CELL (2006)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)
The bone marrow functionally contributes to liver fibrosis
Francesco P. Russo et al.
GASTROENTEROLOGY (2006)
Galectin-3 regulates myofibroblast activation and hepatic fibrosis
NC Henderson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats
Dong-Chang Zhao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality
ER Miller et al.
ANNALS OF INTERNAL MEDICINE (2005)
Commitment of bone marrow cells to hepatic stellate cells in mouse
S Baba et al.
JOURNAL OF HEPATOLOGY (2004)
Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow
S Gronthos et al.
JOURNAL OF CELL SCIENCE (2003)
Treatment of liver failure in rats with end-stage cirrhosis by transplantation of immortalized hepatocytes
J Cai et al.
HEPATOLOGY (2002)
Plasma transforming growth factor-β1 level and efficacy of α-tocopherol in patients with non-alcoholic steatohepatitis:: a pilot study
T Hasegawa et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Share Paper
